Table 1 Baseline demographic characteristics

Gender male, n (%)

114 (57)

58 (58)

56 (56)

0.77

Age (years)

82 (77–86)

82 (77–85)

82 (77–86)

0.85

BMI (kg/m2)

27.4 (24.4–31.4)

27 (24.5–31.1)

27.9 (24.4–32.4)

0.64

BSA (m2)

1.87 (1.7–2.03)

1.88 (1.68–2.03)

1.87 (1.73–2)

0.91

Logistic Euroscore

10.4 (7–16)

10.7 (7.1–15.5)

10.2 (7–16.4)

0.76

DM, n (%)

53 (26.5)

27 (27)

26 (26)

0.87

Smoking, n (%)

110 (55)

53 (53)

57 (57)

0.57

Creatinine (umol/L)

88 (71–104)

84.5 (68.5–102)

89.5 (76–108)

0.24

Dialysis, n (%)

3 (1.5)

1 (1)

2 (2)

0.56

Previous MI, n (%)

29 (14.5)

10 (10)

19 (19)

0.07

Previous cardiac surgery, n (%)

25 (12.5)

11 (11)

14 (14)

0.52

Previous PCI, n (%)

36 (18)

13 (13)

23 (23)

0.07

CCS

 I-II, n (%)

32 (16)

14 (14)

18 (18)

 III-IV, n (%)

1 (0.5)

1 (1)

0

0.5

NYHA

 I-II, n (%)

48 (24)

25 (25)

23 (23)

 III-IV, n (%)

152 (76)

75 (75)

77 (77)

0.74

Vmax (m/sec)

4.2 (3.9–4.6)

4.2 (3.9–4.6)

4.2 (3.9–4.7)

0.45

mPG (mmHg)

43 (37–53)

43 (35–53)

44 (37–54)

0.35

pPG (mmHg)

70 (61–86)

70 (60–86)

70 (62–87)

0.41

AVA (cm²)

0.69 (0.56–0.80)

0.7 (0.6–0.8)

0.67 (0.51–0.78)

0.02

Pathology

 Stenosis, n (%)

196 (98)

99 (99)

97 (97)

 Mixed, n (%)

4 (2)

1 (1)

3 (3)

0.3

Bicuspid aortic valve, n (%)

20 (10)

12 (12)

8 (8)_

0.35

LVF

  > 50%, n (%)

171 (85.5)

85 (85)

86 (86)

 30–50%, n (%)

21 (10.5)

11 (11)

10 (10)

  < 30%, n (%)

8 (4)

4 (4)

4 (4)

0.97

CAD

 No, n (%)

145 (72.5)

76 (76)

69 (69)

 1vd, n (%)

29 (14.5)

13 (13)

16 (16)

 2vd, n (%)

20 (10)

9 (9)

11 (11)

 3vd, n (%)

6 (3)

2 (2)

4 (4)

0.68

LMS disease

  > 50%, n (%)

5 (2.5)

3 (3)

2 (2)

0.65